Enfusion, INC 8-K filings

Enfusion, Inc. has completed its merger with Clearwater Analytics Holdings, Inc., resulting in Enfusion becoming a wholly-owned subsidiary of Clearwater.

Enfusion, Inc. stockholders voted to approve the merger agreement with Clearwater Analytics at a special meeting held on April 17, 2025.

Clearwater Analytics and Enfusion have announced the preliminary results of the election by Enfusion shareholders regarding the form of merger consideration they wish to receive in connection with Clearwater's acquisition of Enfusion.

Enfusion amends its definitive proxy statement/prospectus related to its acquisition by Clearwater Analytics, addressing stockholder lawsuits and providing supplemental financial projections.

Enfusion and Clearwater Analytics announce the deadline for Enfusion shareholders to elect the form of merger consideration they wish to receive in connection with Clearwater's acquisition of Enfusion is April 16, 2025.

Enfusion reports a 13.9% increase in Q4 revenue and announces its acquisition by Clearwater Analytics, expected to close in the second quarter of 2025.

Enfusion and Clearwater Analytics announced the expiration of the Hart-Scott-Rodino Act waiting period, a key step toward Clearwaters acquisition of Enfusion, with the transaction expected to close in the second quarter of 2025.

Clearwater Analytics is set to acquire Enfusion for $1.5 billion in a mix of cash and stock, aiming to create a unified front-to-back platform for investment management.

Enfusion announced a strong third quarter in 2024, achieving 15.4% year-over-year revenue growth and a record 894 clients.

Enfusion announced a strong second quarter with a 16% year-over-year revenue increase and expansion of adjusted EBITDA margin, driven by new client wins and product enhancements.

Enfusion, Inc.'s Board of Directors has approved a new Executive Severance Policy providing benefits to certain executives upon qualifying terminations.

Enfusion, Inc. held its 2024 Annual Meeting of Stockholders on June 13, 2024, where stockholders voted on the election of Class III directors and the ratification of the appointment of the independent accounting firm.

Enfusion's first quarter of 2024 saw a 17.3% year-over-year revenue increase and significant expansion in adjusted EBITDA margin.

Enfusion presented its growth strategy at its Investor Day, highlighting a $25 billion total addressable market and a focus on expanding its SaaS platform.

Enfusion's Q4 2023 results show a significant increase in revenue and improved profitability, driven by strong client wins and strategic product investments.

Enfusion, a provider of cloud-based software for investment managers, has promoted Valeria Gutowski to Chief Accounting Officer, effective January 15, 2024.